← Evidence map

ArticleJournal for immunotherapy of cancer2018

Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy.

George Fromm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

37 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 30563566